en POLSKI
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2024
vol. 30
 
Share:
Share:
abstract:
Original paper

Emotional and behavioural functioning in children with tyrosinaemia type 1

Monika Pohorecka
1
,
Marcin Biernacki
2
,
Anna Jakubowska-Winecka
3
,
Kinga Leszczynska-Iwanicka
3
,
Dariusz Rokicki
4
,
Paulina Pokora
4
,
Barbara Perkowska
4
,
Magdalena Pajdowska
5
,
Marta Biernacka
3

  1. Clinical Department of Pediatrics and Allergology, National Medical Institute of the Ministry of Interior and Administration, Warsaw, Poland
  2. Department of Aviation Psychology, Military Institute of Aviation Medicine, Warsaw, Poland
  3. Department of Health Psychology, Children’s Memorial Health Institute, Warsaw, Poland
  4. Department of Pediatrics, Nutritional and Metabolic Diseases, Children’s Memorial Health Institute, Warsaw, Poland
  5. Laboratory, Masdiag Sp.z o.o., Warsaw, Poland
Pediatr Endocrinol Diabetes Metab 2024; 30 (1): 8-13
Online publish date: 2024/04/14
View full text Get citation
 
PlumX metrics:
Introduction
Tyrosinaemia type I is a rare hereditary metabolic disease caused by deficiency of the enzyme involved in the breakdown of tyrosine. Since the use of nitisinone in addition to diet in 1992, survival rates have increased significantly, but more and more socio-emotional problems have become apparent. The aim of the study was the assessment the relationship between variations in serum tyrosine and phenylalanine levels and measurements of socio-emotional functioning and determination of patients’ IQs.

The aim of the study
was the assessment the relationship between variations in serum tyrosine and phenylalanine levels and measurements of socio-emotional functioning and determination of patients’ IQs.

Material and methods
Twelve children were studied, from a single centre, born between 1994 and 2012, treated with nitisinone and a low-phenylalanine and -tyrosine diet. The psychological evaluation was conducted using the parent form of the Child Behaviour Checklist (CBCL)/4–18. Additionally, the patients’ IQs were measured using the Stanford-Binet 5 (SB5) Intelligence Scale. Statistical analyses were performed using PAWS software suite version 26. We found that phenylalanine variability over time correlated with measures of emotional and behavioural functioning. This relationship holds true for externalising behaviour, associated with the experience of maladjustment and aggression. Total score intellectual and cognitive function was within the norm for all patients.

Conclusions
To maintain better quality of life for patients and their families in terms of emotional and behavioural functioning, it may be important to avoid spikes (significant fluctuations) in phenylalanine levels. Regular, detailed psychological evaluations are recommended to detect potential problems and implement interventions aimed at achieving the best possible individual development and realise the intellectual and behavioural potential, thereby improving the patient's and her family's quality of life.

keywords:

tyrosinaemia type 1, emotional and behavioural functioning, phenylalanine


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.